Experience with ABO-Incompatible Liver Transplantation



Though the possibility of super acute and acute rejection of ABO-imcompitable organ transplantation in liver is smaller than in kidney due to no blood group antigen expression on hepatocellular surface, but as a result of bile duct epithelial cells express blood group antigen, caused by the bile duct damage is relatively serious, therefore, the authors suggest that conventional plasma desensitization treatment must be done before ABOi-liver transplant. In this chapter, the indications, plasma desensitization scheme, and postoperative management of ABOi-liver are described.


ABOi-liver transplantation Transplantation indications Plasma desensitization scheme Postoperative management 


  1. 1.
    Skogsberg U, Breimer ME, Friman S, et al. Adult abo-incompatible liver transplantation, using a and b donors. Xenotransplantation. 2006;13:154–9.CrossRefGoogle Scholar
  2. 2.
    Busquets J, Castellote J, Torras J, et al. Liver transplantation across rh blood group barriers increases the risk of biliary complications. J GastrointestSurg. 2007;11:458–63.CrossRefGoogle Scholar
  3. 3.
    Hanto DW, Fecteau AH, Alonso MH, et al. Abo-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl. 2003;9:22–30.CrossRefGoogle Scholar
  4. 4.
    Usui M, Isaji S, Mizuno S, et al. Experiences and problems pre-operative anti-cd20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for abo-incompatible living-donor liver transplantation. Clin Transplant. 2007;21:24–31.CrossRefGoogle Scholar
  5. 5.
    Lee CF, Cheng CH, Wang YC, et al. Adult living donor liver transplantation across abo-incompatibility. Medicine (Baltimore). 2015;94:e1796.CrossRefGoogle Scholar
  6. 6.
    Urbani L, Mazzoni A, De Simone P, et al. Treatment of antibody-mediated rejection with high-dose immunoglobulins in abo-incompatible liver transplant recipient. Transpl Int. 2007;20:467–70.CrossRefGoogle Scholar
  7. 7.
    Ikegami T, Taketomi A, Soejima Y, et al. Successful abo incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. Transplant Proc. 2007;39:3491–4.CrossRefGoogle Scholar
  8. 8.
    Urbani L, Mazzoni A, Bianco I, et al. The role of immunomodulation in abo-incompatible adult liver transplant recipients. J Clin Apher. 2008;23:55–62.CrossRefGoogle Scholar
  9. 9.
    Egawa H, Ohdan H, Haga H, et al. Current status of liver transplantation across abo blood-type barrier. J Hepatobiliary Pancreat Surg. 2008;15:131–8.CrossRefGoogle Scholar
  10. 10.
    Haga H, Egawa H, Shirase T, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in abo-incompatible liver transplantation. Liver Transpl. 2004;10:16–27.CrossRefGoogle Scholar
  11. 11.
    Sanchez-Urdazpal L, Batts KP, Gores GJ, et al. Increased bile duct complications in liver transplantation across the abo barrier. Ann Surg. 1993;218:152–8.CrossRefGoogle Scholar
  12. 12.
    Sato Y, Yamamoto S, Oya H, et al. Adult abo-incompatible liver transplantation by intraportal transfusion of donor-specific antigen: a case report. Transplant Proc. 2008;40:2811–4.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Lin Wei
    • 1
  1. 1.Beijing Friendship HospitalCapital Medical UniversityBeijingChina

Personalised recommendations